The Ensign Group IncENSG
▲ PositiveCapitalrelevance
Raises 2026 guidance after Q2 earnings beat, boosting earnings and revenue outlook.
Impact on stocks 1
Aging Population
The Ensign Group IncEnsign Group lifted its full-year 2026 earnings and revenue guidance following a second-quarter earnings beat. The company now expects diluted earnings per share of US$7.75 to US$7.85 and revenue of US$5.87 billion to US$5.92 billion, citing strong second-quarter trading. The stock trades at 27.2 times earnings, above both its estimated fair P/E of 25 times and the US Healthcare industry average of 25.7 times, while a discounted cash flow model suggests fair value of US$198.08 per share, about 10.1% above the current price of US$178.16. Analysts forecast earnings growth of 12.8% a year, with current return on equity at 15.5% and expected return on equity in three years still described as low.
The Ensign Group IncRaises 2026 guidance after Q2 earnings beat, boosting earnings and revenue outlook.